NASDAQ:VTRS - Nasdaq - US92556V1061 - Common Stock - Currency: USD
9.23
-0.3 (-3.15%)
The current stock price of VTRS is 9.23 USD. In the past month the price decreased by -19.18%. In the past year, price decreased by -26.69%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 70.82 | 873.97B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 28.24 | 402.40B | ||
JNJ | JOHNSON & JOHNSON | 16.52 | 397.31B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 21.11 | 236.34B | ||
MRK | MERCK & CO. INC. | 12.07 | 233.36B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.73 | 215.38B | ||
PFE | PFIZER INC | 8.5 | 149.78B | ||
SNY | SANOFI-ADR | 13.55 | 136.57B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 52.3 | 120.92B | ||
GSK | GSK PLC-SPON ADR | 7.96 | 76.71B | ||
ZTS | ZOETIS INC | 28.25 | 75.45B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 32.75 | 45.68B |
Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. The company is headquartered in Canonsburg, Pennsylvania and currently employs 38,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The firm operates manufacturing sites across worldwide that produce oral solid doses, injectables and complex dosage forms.
VIATRIS INC
1000 Mylan Boulevard
Canonsburg PENNSYLVANIA 15317 US
CEO: Michael Goettler
Employees: 33000
Company Website: https://www.viatris.com/en
Investor Relations: https://investor.viatris.com/
Phone: 17245141800
The current stock price of VTRS is 9.23 USD. The price decreased by -3.15% in the last trading session.
The exchange symbol of VIATRIS INC is VTRS and it is listed on the Nasdaq exchange.
VTRS stock is listed on the Nasdaq exchange.
15 analysts have analysed VTRS and the average price target is 13.11 USD. This implies a price increase of 42% is expected in the next year compared to the current price of 9.23. Check the VIATRIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
VIATRIS INC (VTRS) has a market capitalization of 11.02B USD. This makes VTRS a Large Cap stock.
VIATRIS INC (VTRS) currently has 33000 employees.
VIATRIS INC (VTRS) has a resistance level at 11.22. Check the full technical report for a detailed analysis of VTRS support and resistance levels.
The Revenue of VIATRIS INC (VTRS) is expected to decline by -3.52% in the next year. Check the estimates tab for more information on the VTRS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
VIATRIS INC (VTRS) has a dividend yield of 5.04%. The yearly dividend amount is currently 0.48. Check the full fundamental report for a detailed analysis of VTRS dividend history, reliability and sustainability.
VIATRIS INC (VTRS) will report earnings on 2025-05-07, before the market open.
The PE ratio for VIATRIS INC (VTRS) is 3.48. This is based on the reported non-GAAP earnings per share of 2.65 and the current share price of 9.23 USD. Check the full fundamental report for a full analysis of the valuation metrics for VTRS.
The outstanding short interest for VIATRIS INC (VTRS) is 2.53% of its float. Check the ownership tab for more information on the VTRS short interest.
ChartMill assigns a fundamental rating of 4 / 10 to VTRS. While VTRS is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months VTRS reported a non-GAAP Earnings per Share(EPS) of 2.65. The EPS decreased by -9.56% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -1.97% | ||
ROE | -4.46% | ||
Debt/Equity | 0.72 |
ChartMill assigns a Buy % Consensus number of 55% to VTRS. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of 0.16% and a revenue growth -3.52% for VTRS